Here are five things to know:
1. CMS approved the “Interbody Fusion Device, Nanotextured Surface” code as an XRG code.
2. Providers may use the code beginning Oct. 1.
3. Mequon, Wis.-based Titan Spine presented its nanoLOCK technology to CMS, showcasing its uniqueness.
4. Titan Spine’s nanoLOCK technology is the only technology approved by CMS to use the code. However, CMS noted it will add other technologies to this code if companies prove equivalence to the nanoLOCK technology.
5. Titan Spine plans to unveil its next-generation nanoLOCK surface technology, designed to offer exceptional osteogenic and angiogenic environments.
More articles on devices:
NuVasive shares increase 1.42% — 5 quick facts
Amedica closes $12.7M public offering: 4 points
Medtronic lays off 4.1% of global spine division staff: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
